Logo image of HOMI.BR

HOME INVEST BELGIUM (HOMI.BR) Stock Fundamental Analysis

EBR:HOMI - Euronext Brussels - BE0974409410 - REIT - Currency: EUR

20.65  -0.1 (-0.48%)

Fundamental Rating

4

Taking everything into account, HOMI scores 4 out of 10 in our fundamental rating. HOMI was compared to 5 industry peers in the Residential REITs industry. While HOMI has a great profitability rating, there are quite some concerns on its financial health. HOMI has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

HOMI had positive earnings in the past year.
HOMI had a positive operating cash flow in the past year.
Of the past 5 years HOMI 4 years were profitable.
In the past 5 years HOMI always reported a positive cash flow from operatings.
HOMI.BR Yearly Net Income VS EBIT VS OCF VS FCFHOMI.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

1.2 Ratios

With an excellent Return On Assets value of 8.99%, HOMI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
HOMI's Return On Equity of 16.71% is amongst the best of the industry. HOMI outperforms 100.00% of its industry peers.
HOMI's Return On Invested Capital of 2.36% is on the low side compared to the rest of the industry. HOMI is outperformed by 80.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HOMI is in line with the industry average of 3.37%.
The last Return On Invested Capital (2.36%) for HOMI is above the 3 year average (2.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.99%
ROE 16.71%
ROIC 2.36%
ROA(3y)4.75%
ROA(5y)4.76%
ROE(3y)9.08%
ROE(5y)9.52%
ROIC(3y)2.36%
ROIC(5y)2.27%
HOMI.BR Yearly ROA, ROE, ROICHOMI.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

1.3 Margins

With an excellent Profit Margin value of 221.81%, HOMI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Profit Margin of HOMI has remained more or less at the same level.
Looking at the Operating Margin, with a value of 76.47%, HOMI is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
In the last couple of years the Operating Margin of HOMI has grown nicely.
With an excellent Gross Margin value of 92.87%, HOMI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
HOMI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 76.47%
PM (TTM) 221.81%
GM 92.87%
OM growth 3Y2.45%
OM growth 5Y3.82%
PM growth 3Y7.72%
PM growth 5Y0.13%
GM growth 3Y0.61%
GM growth 5Y0.41%
HOMI.BR Yearly Profit, Operating, Gross MarginsHOMI.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HOMI is destroying value.
Compared to 1 year ago, HOMI has more shares outstanding
HOMI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for HOMI has been reduced compared to a year ago.
HOMI.BR Yearly Shares OutstandingHOMI.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
HOMI.BR Yearly Total Debt VS Total AssetsHOMI.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 0.89, we must say that HOMI is in the distress zone and has some risk of bankruptcy.
With a decent Altman-Z score value of 0.89, HOMI is doing good in the industry, outperforming 80.00% of the companies in the same industry.
A Debt/Equity ratio of 0.82 indicates that HOMI is somewhat dependend on debt financing.
The Debt to Equity ratio of HOMI (0.82) is better than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF N/A
Altman-Z 0.89
ROIC/WACC0.46
WACC5.1%
HOMI.BR Yearly LT Debt VS Equity VS FCFHOMI.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 0.31 indicates that HOMI may have some problems paying its short term obligations.
HOMI's Current ratio of 0.31 is on the low side compared to the rest of the industry. HOMI is outperformed by 60.00% of its industry peers.
A Quick Ratio of 0.31 indicates that HOMI may have some problems paying its short term obligations.
HOMI has a Quick ratio of 0.31. This is in the lower half of the industry: HOMI underperforms 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.31
HOMI.BR Yearly Current Assets VS Current LiabilitesHOMI.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 616.03% over the past year.
Measured over the past 5 years, HOMI shows a small growth in Earnings Per Share. The EPS has been growing by 3.82% on average per year.
The Revenue has been growing slightly by 4.92% in the past year.
Measured over the past years, HOMI shows a small growth in Revenue. The Revenue has been growing by 7.71% on average per year.
EPS 1Y (TTM)616.03%
EPS 3Y11.06%
EPS 5Y3.82%
EPS Q2Q%1175.99%
Revenue 1Y (TTM)4.92%
Revenue growth 3Y9.86%
Revenue growth 5Y7.71%
Sales Q2Q%3.94%

3.2 Future

The Earnings Per Share is expected to grow by 2.26% on average over the next years.
Based on estimates for the next years, HOMI will show a small growth in Revenue. The Revenue will grow by 4.53% on average per year.
EPS Next Y2.16%
EPS Next 2Y2.78%
EPS Next 3Y2.26%
EPS Next 5YN/A
Revenue Next Year5.52%
Revenue Next 2Y4.72%
Revenue Next 3Y4.53%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HOMI.BR Yearly Revenue VS EstimatesHOMI.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
HOMI.BR Yearly EPS VS EstimatesHOMI.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 5.04, the valuation of HOMI can be described as very cheap.
HOMI's Price/Earnings ratio is rather cheap when compared to the industry. HOMI is cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.43. HOMI is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 17.16, HOMI is valued on the expensive side.
HOMI's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. HOMI is more expensive than 60.00% of the companies in the same industry.
HOMI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.17.
Industry RankSector Rank
PE 5.04
Fwd PE 17.16
HOMI.BR Price Earnings VS Forward Price EarningsHOMI.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HOMI is valued more expensive than 80.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 29.3
HOMI.BR Per share dataHOMI.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of HOMI may justify a higher PE ratio.
PEG (NY)2.33
PEG (5Y)1.32
EPS Next 2Y2.78%
EPS Next 3Y2.26%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.14%, HOMI is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.53, HOMI is paying slightly less dividend.
HOMI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 4.14%

5.2 History

The dividend of HOMI decreases each year by -8.56%.
Dividend Growth(5Y)-8.56%
Div Incr Years2
Div Non Decr Years2
HOMI.BR Yearly Dividends per shareHOMI.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

14.18% of the earnings are spent on dividend by HOMI. This is a low number and sustainable payout ratio.
DP14.18%
EPS Next 2Y2.78%
EPS Next 3Y2.26%
HOMI.BR Yearly Income VS Free CF VS DividendHOMI.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M
HOMI.BR Dividend Payout.HOMI.BR Dividend Payout, showing the Payout Ratio.HOMI.BR Dividend Payout.PayoutRetained Earnings

HOME INVEST BELGIUM

EBR:HOMI (6/4/2025, 7:00:00 PM)

20.65

-0.1 (-0.48%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)05-21 2025-05-21
Earnings (Next)09-03 2025-09-03
Inst Owners2.96%
Inst Owner ChangeN/A
Ins Owners3.11%
Ins Owner ChangeN/A
Market Cap417.13M
Analysts45.45
Price Target19.55 (-5.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.14%
Yearly Dividend0.58
Dividend Growth(5Y)-8.56%
DP14.18%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 5.04
Fwd PE 17.16
P/S 11.43
P/FCF N/A
P/OCF 19.26
P/B 0.86
P/tB 0.86
EV/EBITDA 29.3
EPS(TTM)4.1
EY19.85%
EPS(NY)1.2
Fwd EY5.83%
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)1.07
OCFY5.19%
SpS1.81
BVpS23.98
TBVpS23.95
PEG (NY)2.33
PEG (5Y)1.32
Profitability
Industry RankSector Rank
ROA 8.99%
ROE 16.71%
ROCE 3.15%
ROIC 2.36%
ROICexc 2.37%
ROICexgc 2.37%
OM 76.47%
PM (TTM) 221.81%
GM 92.87%
FCFM N/A
ROA(3y)4.75%
ROA(5y)4.76%
ROE(3y)9.08%
ROE(5y)9.52%
ROIC(3y)2.36%
ROIC(5y)2.27%
ROICexc(3y)2.37%
ROICexc(5y)2.29%
ROICexgc(3y)2.37%
ROICexgc(5y)2.29%
ROCE(3y)3.14%
ROCE(5y)3.03%
ROICexcg growth 3Y3.18%
ROICexcg growth 5Y3%
ROICexc growth 3Y3.18%
ROICexc growth 5Y3%
OM growth 3Y2.45%
OM growth 5Y3.82%
PM growth 3Y7.72%
PM growth 5Y0.13%
GM growth 3Y0.61%
GM growth 5Y0.41%
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF N/A
Debt/EBITDA 14.18
Cap/Depr 18429.6%
Cap/Sales 98.95%
Interest Coverage 2.37
Cash Conversion 77.04%
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.31
Altman-Z 0.89
F-Score6
WACC5.1%
ROIC/WACC0.46
Cap/Depr(3y)6185.6%
Cap/Depr(5y)5158.09%
Cap/Sales(3y)33.41%
Cap/Sales(5y)31.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)616.03%
EPS 3Y11.06%
EPS 5Y3.82%
EPS Q2Q%1175.99%
EPS Next Y2.16%
EPS Next 2Y2.78%
EPS Next 3Y2.26%
EPS Next 5YN/A
Revenue 1Y (TTM)4.92%
Revenue growth 3Y9.86%
Revenue growth 5Y7.71%
Sales Q2Q%3.94%
Revenue Next Year5.52%
Revenue Next 2Y4.72%
Revenue Next 3Y4.53%
Revenue Next 5YN/A
EBIT growth 1Y10.54%
EBIT growth 3Y12.55%
EBIT growth 5Y11.82%
EBIT Next Year-44.61%
EBIT Next 3Y-15.54%
EBIT Next 5YN/A
FCF growth 1Y-156.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.55%
OCF growth 3Y5.42%
OCF growth 5Y7.98%